[1]
|
Kram Árová, E. and Stiller, C.A. (2005) International Classification Childhood Cancer. Cancer, 103, 1457-1467.
https://doi.org/10.1002/cncr.20910
|
[2]
|
董爽, 于世英. 肿瘤化疗所致恶心呕吐现状调查[J]. 中国循证医学杂志, 2013, 13(6): 687-691.
|
[3]
|
萍萍, 吴春晓, 顾凯, 等. 上海市儿童恶性肿瘤发病情况和时间趋势分析[J]. 中华流行病学杂志, 2016, 37(1): 106-110.
|
[4]
|
Tsuchida, M., Ohara, A., Manabe, A., et al. (2010) Long-Term Results of Tokyo Children’s Cancer Study Group Trials for Childhood Acute Lymphoblastic Leukemia, 1984-1999. Leukemia, 24, 383-396.
https://doi.org/10.1038/leu.2009.260
|
[5]
|
张萍, 李霞, 王啟瑶. 儿童恶性肿瘤发病高危因素研究进展[J]. 重庆医学, 2017(30): 4288-4292.
|
[6]
|
Linabery, A.M. and Ross, J.A. (2008) Childhood and Adolescent Cancer Survival in the US by Race and Ethnicity for the Diagnostic Period 1975-1999. Cancer, 113, 2575-2596. https://doi.org/10.1002/cncr.23866
|
[7]
|
Ljungman, G., Jakobson, A., Behrendtz, M., et al. (2011) Incidence and Survival Analyses in Children with Solid Tumors Diagnosed in Sweden between 1983 and 2007. Acta Paediatrica, 100, 750-757.
https://doi.org/10.1111/j.1651-2227.2010.02122.x
|
[8]
|
智勇, 高黎, 徐国镇, 等. 初治鼻咽癌调强放疗的初步结果[J]. 中华放射肿瘤学杂志, 2006, 15(4): 237-243.
|
[9]
|
Llen, A.M., Pawlicki, T., Dong, L., et al. (2012) An Evi-dence Based Review of Proton Beam Therapy: The Report of ASTRO’s Emerging Technology Committee. Radiotherapy & Oncology, 103, 8-11.
https://doi.org/10.1016/j.radonc.2012.02.001
|
[10]
|
Oeffinger, K.C., Eshelman, D.A., Tomlinson, G.E., et al. (2000) Grading of Late Effects in Young Adult Survivors of Childhood Cancer Followed in an Ambulatory Adult Setting. Cancer, 88, 1687-1695.
https://doi.org/10.1002/(SICI)1097-0142(20000401)88:7%3C1687::AID-CNCR24%3E3.0.CO;2-M
|
[11]
|
Mulhern, R.K. and Palmer, S.L. (2003) Neurocognitive Late Effects in Pediatric Cancer. Current Problems in Cancer, 27, 177-197. https://doi.org/10.1016/S0147-0272(03)00026-6
|
[12]
|
Gurney, J.G., Kadan-Lottick, N.S., Packer, R.J., et al. (2003) Endocrine and Cardiovascular Late Effects among Adult Survivors of Childhood Brain Tumors: Childhood Cancer Survivor Study. Cancer, 97, 663-673.
https://doi.org/10.1002/cncr.11095
|
[13]
|
Follin, C. and Erfurth, E.M. (2016) Long-Term Effect of Cranial Radio-therapy on Pituitary-Hypothalamus Area in Childhood Acute Lymphoblastic Leukemia Survivors. Current Treatment Options in Oncology, 17, 50.
https://doi.org/10.1007/s11864-016-0426-0
|
[14]
|
Hull, M.C., Morris, C.G., Pepine, C.J., et al. (2003) Valvular Dysfunctionand Carotid-Subclavian, and Coronary Artery Disease in Survivors of Hodgkin Lymphoma Treated with Radiation Therapy. JAMA, 290, 2831-2837.
https://doi.org/10.1001/jama.290.21.2831
|
[15]
|
Kahn, J.M., Keegan, T.H., Tao, L., et al. (2016) Racial Disparities in the Survival of American Children, Adolescents, and Young Adults with Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, and Hodgkin Lymphoma. Cancer, 122, 2723-2730. https://doi.org/10.1002/cncr.30089
|
[16]
|
王国民. 儿童肿瘤放射治疗学[M]. 第2版. 上海: 上海科学出版社, 2007: 138.
|
[17]
|
Sterzing, F., Hauswald, H., Uhl, M., et al. (2010) Spinal Cord Sparing Reirradiation with Helical Tomotherapy. Cancer, 116, 3961-3968. https://doi.org/10.1002/cncr.25187
|
[18]
|
Sandlund, J.T. and Hudson, M.M. (2010) Hematology Treatment Strategies for Pediatric Hodgkin Lymphoma. Nature Reviews Clinical Oncology, 7, 243-244. https://doi.org/10.1038/nrclinonc.2010.48
|
[19]
|
Wolden, S.L., Chen, L., Kelly, K.M., et al. (2012) Long-Term Results of CCG5942: A Randomized Comparison of Chemotherapy with and without Radiotherapy for Children with Hodgkin’s Lymphoma—A Report from the Children’s Oncology Group. Journal of Clinical Oncology, 30, 3174-3180. https://doi.org/10.1200/JCO.2011.41.1819
|
[20]
|
Dörffel, W., Rühl, U., Lüders, H., et al. (2013) Treatment of Children and Adolescents with Hodgkin Lymphoma without Radiotherapy for Patients in Complete Re-mission after Chemotherapy: Final Results of the Multinational Trial GPOH-HD95. Journal of Clinical Oncology, 31, 1562-1568. https://doi.org/10.1200/JCO.2012.45.3266
|
[21]
|
Mauz-Körholz, C., Gorde-Grosjean, S., Hasenclever, D., et al. (2007) Resection Alone in 58 Children with Limited Stage, Lymphocyte-Predominant Hodgkin Lympho-ma-Experience from the European Network Group on Pediatric Hodgkin Lymphoma. Cancer, 110, 179-185. https://doi.org/10.1002/cncr.22762
|
[22]
|
Mandell, L.R., Wollner, N. and Fuks, Z. (1987) Is Cranial Radiation Necessary for CNS Prophylaxis in Pediatric NHL. International Journal of Radiation Oncology, Biology, Physics, 13, 359-363.
https://doi.org/10.1016/0360-3016(87)90009-5
|
[23]
|
Cohn, S.L., Pearson, A.D., London, W.B., et al. (2009) The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report. Clinical On-cology, 27, 289-297.
https://doi.org/10.1200/JCO.2008.16.6785
|
[24]
|
DuBois, S.G., Chesler, L., Groshen, S., et al. (2012) Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuro-blastoma: A New Approaches to Neuroblastoma Therapy Trial. Clinical Cancer Research, 18, 2679-2686. https://doi.org/10.1158/1078-0432.CCR-11-3201
|
[25]
|
Wilson, J.S., Gains, J.E., Moroz, V., Wheathley, K. and Gaze, M.N. (2014) Systematic Review of (131)I-Meta Iodobenzylguanidine Molecular Radiotherapy for Neuroblastoma. European Journal of Cancer, 50, 801-815.
https://doi.org/10.1016/j.ejca.2013.11.016
|
[26]
|
Abramson, D.H. (2005) Retinoblastoma in the 20th Century: Past Success and Future Challenges the Weisenfeld Lecture. Investigative Ophthalmology & Visual Science, 46, 2684 -2691. https://doi.org/10.1167/iovs.04-1462
|
[27]
|
陆烨, 童剑萍. 视网膜母细胞瘤的发生机制及诊断和治疗进展[J]. 现代肿瘤医学, 2016, 24(6): 1007-1014.
|
[28]
|
Hu, X., Fang, Y., Hui, X., Jv, Y. and You, C. (2016) Radiotherapy for Diffuse Brainstem Glioma in Children and Young Adults. The Cochrane Database of Systematic Reviews, 27, CD010439.
https://doi.org/10.1002/14651858.CD010439.pub2
|
[29]
|
Hug, E.B., Muenter, M.W., Archambeau, J.O., et al. (2002) Conformal Proton Radiation Therapy for Pediatric Low-Grade Astrocytomas. Strahlentherapie und Onkologie, 178, 10-17. https://doi.org/10.1007/s00066-002-0874-2
|
[30]
|
Metzger, M.L. and Dame, J.S. (2005) Current Therapy for Wilms’ Tumor. Oncologist, 10, 815-826.
https://doi.org/10.1634/theoncologist.10-10-815
|
[31]
|
Pritchard-Jones, K., et al. (2015) Omission of Doxorubicin from the Treatment of Stage II-III, Intermediate-Risk Wilms’ Tumour (SIOP WT 2001): An Open-Label, Non-Inferiority, Randomised Controlled Trial. The Lancet, 386, 1156-1164. https://doi.org/10.1016/S0140-6736(14)62395-3
|
[32]
|
Kalapurakal, J.A., Li, S.M., Breslow, N.E., et al. (2003) Influence of Radiation Therapy Delay on Abdominal Tumor Recurrence in Patients with Favorable Histology Wilms’ Tumor Treated on NWTS-3 and NWTS-4: A Report from the National Wilms’ Tumor Study Group. International Journal of Radiation, Oncology, Biology, Physics, 57, 495-499.
https://doi.org/10.1016/S0360-3016(03)00598-4
|
[33]
|
Ries, L.A.G., Smith, M.A., Gurney, J.G., et al. (1999) Cancer Incidence and Survival among Children and Adolescents. United States SEER Program 1975-1995, National Cancer Institute, SEER Program, NIH Pub. No. 99-4649, Bethesda, 112-122.
|
[34]
|
Dasgupta, R., Fuchs, J. and Rodeberg, D. (2016) Rhabdomyosarcoma. Seminars in Pediatric Surgery, 25, 276-283.
https://doi.org/10.1053/j.sempedsurg.2016.09.011
|